Factor VIII Products and Inhibitors in Severe Hemophilia A

被引：12
|
作者：
Iorio, Alfonso [1 ]
Skinner, Mark W.
Makris, Mike [2 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2013年 / 368卷 / 15期
关键词：
D O I：
10.1056/NEJMc1301995
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1456 / 1456
页数：1
相关论文
共 50 条
  • [21] Genetic Characterization of the Factor VIII Gene in a Cohort of Colombian Patients with Severe Hemophilia A with Inhibitors
    Doncel, Samuel Sarmiento
    Mosquera, Gina Alejandra Diaz
    Pelaez, Ronald Guillermo
    Cortes, Javier Mauricio
    Rico, Carol Agudelo
    Cadavid, Francisco Javier Meza
    Plazas, Nelson Ramirez
    Amar, Ivan Alfredo Perdomo
    Siado, Jorge Enrique Pena
    Rey, Fabian Andres Parrado
    Montano, Cesar Alberto
    Villadiego, Alexys Maza
    HEMATOLOGY REPORTS, 2022, 14 (02) : 149 - 154
  • [22] Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A
    Repesse, Yohann
    Costa, Catherine
    Palla, Roberta
    Moshai, Elika Farrokhi
    Borel-Derlon, Annie
    D'Oiron, Roseline
    Rothschild, Chantal
    El-Beshlawy, Amal
    Elalfy, Mohsen
    Ramanan, Vijay
    Eshghi, Peyman
    Oldenburg, Johannes
    Pavlova, Anna
    Rosendaal, Frits R.
    Peyvandi, Flora
    Kaveri, Srinivas V.
    Lacroix-Desmazes, Sebastien
    HAEMATOLOGICA, 2019, 104 (08) : E369 - E372
  • [23] Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A
    Calvez, Thierry
    Chambost, Herve
    Claeyssens-Donadel, Segolene
    d'Oiron, Roseline
    Goulet, Veronique
    Guillet, Benoit
    Heritier, Virginie
    Milien, Vanessa
    Rothschild, Chantal
    Roussel-Robert, Valerie
    Vinciguerra, Christine
    Goudemand, Jenny
    BLOOD, 2014, 124 (23) : 3398 - 3408
  • [24] Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011
    Collins, Peter W.
    Palmer, Benedict P.
    Chalmers, Elizabeth A.
    Hart, Daniel P.
    Liesner, Ri
    Rangarajan, Savita
    Talks, Katherine
    Williams, Michael
    Hay, Charles R. M.
    BLOOD, 2014, 124 (23) : 3389 - 3397
  • [25] Induction of factor VIII tolerance by hemophilia gene transfer to eradicate factor VIII inhibitors
    Young, Guy
    BLOOD ADVANCES, 2025, 9 (02) : 265 - 269
  • [26] Transient factor VIII inhibitors in two patients with hemophilia A
    Pollmann, H
    Richter, H
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2658 - P2658
  • [27] Factor VIII inhibitors in mild/moderate hemophilia A.
    Hay, CRM
    Ludlam, CA
    Colvin, BT
    Hill, F
    Preston, FE
    Berntorp, E
    Bunschoten, EPM
    Fijnvandraat, K
    Kasper, CK
    Mannucci, PM
    Santagostino, E
    Sultan, Y
    White, G
    BLOOD, 1996, 88 (10) : 3024 - 3024
  • [28] Factor VIII inhibitors in hemophilia A: rationale and latest evidence
    Witmer, Char
    Young, Guy
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2013, 4 (01) : 59 - 72
  • [29] Complications of hemophilia a treatment. Factor VIII inhibitors
    1600, Publ by New York Acad of Sciences, New York, NY, USA (614):
  • [30] Prevalence of factor VIII inhibitors in patients with hemophilia A in Brazil
    Rieger, A
    Roisenberg, I
    THROMBOSIS AND HAEMOSTASIS, 1999, 81 (03) : 475 - 476
12345